» Articles » PMID: 21139970

Non-surgical Treatment of Primary Female Urethral Cancer

Overview
Journal Rare Tumors
Publisher Sage Publications
Specialty Oncology
Date 2010 Dec 9
PMID 21139970
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Primary carcinomas of the female urethra are extremely rare, with an annual incidence of less than ten in one million. Currently, there is no consensus regarding management of this malignancy. However, there have been several case reports demonstrating the efficacy of chemoradiation in the treatment of female urethral cancer. In this report we present two cases of female primary urethral adenocarcinoma that were treated by concomitant chemotherapy and external beam radiotherapy, followed by interstitial brachytherapy.

Citing Articles

Management of Primary Female Urethral Adenocarcinoma: Two Rare Case Reports and Literature Review.

Tian J, Zhu T, Xu Z, Chen X, Wu Y, Fu G Medicina (Kaunas). 2023; 59(1).

PMID: 36676733 PMC: 9865078. DOI: 10.3390/medicina59010109.


Progress in the treatment of urethral adenocarcinoma.

Guo J, Liang X, Zheng Y, Ma J J Cancer Res Clin Oncol. 2022; 149(6):2693-2698.

PMID: 36414814 DOI: 10.1007/s00432-022-04481-5.


Incidence rates and contemporary trends in primary urethral cancer.

Wenzel M, Nocera L, Colla Ruvolo C, Wurnschimmel C, Tian Z, Shariat S Cancer Causes Control. 2021; 32(6):627-634.

PMID: 33751293 PMC: 8089076. DOI: 10.1007/s10552-021-01416-2.


Palladium interstitial implant in combination with external beam radiotherapy and chemotherapy for the definitive treatment of a female urethral carcinoma.

Bagshaw H, Williams N, Huang Y, Tward J, Gaffney D Gynecol Oncol Rep. 2015; 13:40-3.

PMID: 26425719 PMC: 4563585. DOI: 10.1016/j.gore.2015.06.001.


Successful management of female urethral carcinoma with radiation therapy and concurrent chemotherapy.

Magnuson W, Bradley K, Shaves M Gynecol Oncol Case Rep. 2013; 2(1):1-3.

PMID: 24371597 PMC: 3860990. DOI: 10.1016/j.gynor.2011.10.006.

References
1.
Swartz M, Porter M, Lin D, Weiss N . Incidence of primary urethral carcinoma in the United States. Urology. 2006; 68(6):1164-8. DOI: 10.1016/j.urology.2006.08.1057. View

2.
Nicholson S, Tsang D, Summerton D . Aggressive combined-modality therapy for squamous cell carcinoma of the female urethra. Nat Clin Pract Urol. 2008; 5(10):574-7. DOI: 10.1038/ncpuro1211. View

3.
Gillitzer R, Hampel C, Wiesner C, Hadaschik B, Thuroff J . Single-institution experience with primary tumours of the male urethra. BJU Int. 2007; 101(8):964-8. DOI: 10.1111/j.1464-410X.2007.07347.x. View

4.
Kent D, Gee J, Amato R, Pisters L . Successful management of metastatic urethral cancer with organ preservation. J Urol. 2001; 166(6):2308. View

5.
Kawashima A, Sandler C, Wasserman N, LeRoy A, King Jr B, Goldman S . Imaging of urethral disease: a pictorial review. Radiographics. 2004; 24 Suppl 1:S195-216. DOI: 10.1148/rg.24si045504. View